Diaceutics PLC Investor Relations

Investor Overview

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharma companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.

DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of labs.

Diaceutics' data capability is one of the three key value drivers it has integrated into its unique DXRX platform alongside its global lab network and product suite tailored for precision testing.

FY2024 Results Investor Meets Company Presentation

Diaceutics’ CEO Ryan Keeling and CFO Nick Roberts provided an update on the Company's  Full Year 2024 results on May 13th.

PMx Capital Markets Event

December 4th, 2024

Virtual Capital Markets Event

June 12, 2024

Upcoming Events

2025

Diaceutics Full Year 2024 Results Analyst Presentation, 1400 BST
13th May
Investor Meet Company Presentation, 1530 BST
13th May

Why invest in Diaceutics?

Have a question?

PMx Capital Markets Event

December 4th, 2024

Virtual Capital Markets Event

June 12, 2024

Upcoming Events

2025

Diaceutics Full Year 2024 Results Analyst Presentation, 1400 BST
13th May
Investor Meet Company Presentation, 1530 BST
13th May

Why invest in Diaceutics?

Have a question?

Featured Investor News

Investor Alerts

If you would like to recieve investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.